Search Results - "Harputluoglu, H."

Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results by Esin, E., Cakmak Oksuzoglu, O.B., Bilici, A., Cicin, I., Aksoy, S., Alacacioglu, A., Kaplan, M.A., Cabuk, D., Sumbul, A.T., Paydas, S., Sakin, A., Er, Ö, Korkmaz, T., Yildirim, N., Artac, M., Harputluoglu, H., Yumuk, P.F., Basaran, G., Oyan Uluc, B., Demirci, U.

Get full text

Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience by Aksoy, S., Dizdar, O., Harputluoglu, H., Altundag, K.

Get full text

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes by Esin, Ece, Oksuzoglu, B., Bilici, A., Cicin, I., Kostek, O., Kaplan, M. A., Aksoy, S., Aktas, B. Y., Ozdemir, O., Alacacioglu, A., Cabuk, D., Sumbul, A. T., Sakin, A., Paydas, S., Yetisir, E., Er, O., Korkmaz, T., Yildirim, N., Sakalar, T., Demir, H., Artac, M., Karaagac, M., Harputluoglu, H., Bilen, E., Erdur, E., Degirmencioglu, S., Aliyev, A., Cil, T., Olgun, P., Basaran, G., Gumusay, O., Demir, A., Tanrikulu, E., Yumuk, P. F., Imamoglu, Inanc, Oyan, B., Cetin, B., Haksoyler, V., Karadurmus, N., Erturk, I., Evrensel, T., Yilmaz, H., Beypinar, I., Kocer, M., Pilanci, K. N., Seker, M., Urun, Y., Yildirim, N., Eren, T., Demirci, U.

“…Purpose In this study, we aimed to describe the real-life practice outcomes of pertuzumab–trastuzumab–taxane (PTT) combination in visceral organ metastatic,…”
Get full text

How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2? by Harputluoglu, H., Altundag, K.

Get full text

Erectile dysfunction in testicular cancer patients treated with chemotherapy by Tasdemir, C., Firdolas, F., Harputluoglu, H., Altintas, R., Gunes, A.

“…Summary Information on male potency in testicular cancer (TC) patients treated with chemotherapy is insufficient. We aimed to assess the levels of depression…”
Get full text

Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors by AKSOY, S., KILICKAP, S., HAYRAN, M., HARPUTLUOGLU, H., KOCA, E., DEDE, D. S., ERMAN, M., TURKER, A.

“…Summary Though not very common, solid tumor involvement of the bone marrow (BM) may have serious consequences. Recent studies have shown that mean platelet…”
Get full text

Malignancies after rituximab treatment: just coincidence or more? by Aksoy, S, Arslan, C, Harputluoglu, H, Dizdar, O, Altundag, K

“…Rituximab has been successfully used in the treatment of B-cell non-Hodgkin's lymphoma (NHL) and some autoimmune diseases nearly for a decade. Several other…”
Get more information

Vitamin D intake may be effective in the management of triple-negative breast cancer by Harputluoglu, H, Dizdar, O, Karaahmet, F, Altundag, K

Get more information

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study by Harbeck, N., Rastogi, P., Martin, M., Tolaney, S.M., Shao, Z.M., Fasching, P.A., Huang, C.S., Jaliffe, G.G., Tryakin, A., Goetz, M.P., Rugo, H.S., Senkus, E., Testa, L., Andersson, M., Tamura, K., Del Mastro, L., Steger, G.G., Kreipe, H., Hegg, R., Sohn, J., Guarneri, V., Cortés, J., Hamilton, E., André, V., Wei, R., Barriga, S., Sherwood, S., Forrester, T., Munoz, M., Shahir, A., San Antonio, B., Nabinger, S.C., Toi, M., Johnston, S.R.D., O’Shaughnessy, J., Jimenez, M.M., Johnston, S., Boyle, F., Steger, G.G., Neven, P., Jiang, Z., Campone, M., Huober, J., Shimizu, C., Cicin, I., Wardley, A., Tolaney, S.M., Abuin, G.G., Zarba, J., Lim, E., Sant, P., Liao, N., Christiansen, B., Eigeliene, N., Martin-Babau, J., Ettl, J., Mavroudis, D., Chiu, J., Boer, K., Nagarkar, R., Paluch-Shimon, S., Moscetti, L., Sagara, Y., Kim, S.-B., Maciel, M.M., Tjan-Heijnen, V., Broom, R., Lacko, A., Schenker, M., Volkov, N., Sim Yap, Y., Coccia-Portugal, M., Ángel García Sáenz, J., Andersson, A., Chao, T.-Y., Gokmen, E., Harputluoglu, H., Berzoy, O., Patt, D., McArthur, H., Chew, H., Chalasani, P., Kaufman, P., Tedesco, K., Graff, S.L.

“…Adjuvant abemaciclib combined with endocrine therapy (ET) previously demonstrated clinically meaningful improvement in invasive disease-free survival (IDFS)…”
Get full text

1261TiP CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA) by Esposito, F.M., Lee, J., Rha, S.Y., Penkov, K.D., Moisseev, A., Van Den Eynde, M., Prenen, H., Díez García, M., Gumus, M., Sagawa, T., Nechaeva, M., Kajiwara, T., Harputluoglu, H., Charbonnier, L., Bensfia, S., Yang, N., Oh, D-Y.

Get full text

Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients by ELKIRAN, T, HARPUTLUOGLU, H, YASAR, U, BABAOGLU, M. O, DINCEL, A. K, ALTUNDAG, K, OZISIK, Y, GULER, N, BOZKURT, A

“…Cyclophosphamide (CPA) and adriamycin (ADR) are widely used drugs for cancer chemotherapy. It has been reported that CPA and ADR singly or in combination could…”
Get full text

P-92 Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study by Artac, M., Cubukcu, E., Bozkurt, O., Bilici, A., Celik, S., Ozcelik, M., Oven, B., Simsek, E., Geredeli, C., Karaca, M., Cil, T., Harputluoglu, H., Şendur, M., Turk, H., Kefeli, U., Alacacioglu, A., Tural, D., Sakin, A., Karadurmus, N., Çevik, D., Dane, F., Gumus, M.

Get full text

P-90 First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis by Isıkdogan, A., Turk, H., Bilir, C., Şendur, M., Karabulut, B., Artac, M., Cicin, I., Geredeli, C., Alacacioglu, A., Kefeli, U., Harputluoglu, H., Bozkurt, O., Cubukcu, E., Tural, D., Sakin, A., Cil, T., Dane, F., Çevik, D., Arslan, Ç., Karadurmus, N., Gumus, M., Yalcin, S.

Get full text

P-219 Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study by Ç. Arslan, Kefeli, U., Yildirim, E., Isıkdogan, A., Karadurmus, N., Karabulut, B., Cicin, I., Cubukcu, E., Bilir, C., Ozcelik, M., Cil, T., Celik, S., Bozkurt, O., Harputluoglu, H., Oven, B., Geredeli, C., Tural, D., Sakin, A., Çevik, D., Gumus, M., Yalcin, S.

Get full text

LBA2 First-line (1L) durvalumab (D) + platinum-etoposide (EP) for patients (pts) with extensive-stage SCLC (ES-SCLC): Primary results from the phase IIIb LUMINANCE study by Reinmuth, N., Özgüroğlu, M., Leighl, N.B., Galetta, D., Hacibekiroglu, I., Roubec, J., Sendur, M.A.N., Bria, E., Cicin, I., Grohé, C., Harputluoglu, H., Kilickap, S., Novello, S., Opalka, P., Riccardi, F., Ruseva, R.K., Lang, S., Hodari, M., Donner, N., de Marinis, F.

Get full text

325PPertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results by Esin, E, Cakmak Oksuzoglu, O B, Bilici, A, Cicin, I, Aksoy, S, Alacacioglu, A, Kaplan, M A, Cabuk, D, Sumbul, A T, Paydas, S, Sakin, A, Er, Ö, Korkmaz, T, Yildirim, N, Artac, M, Harputluoglu, H, Yumuk, P F, Basaran, G, Oyan Uluc, B, Demirci, U

Get full text

Abstract P3-01-21: Is lymph node ratio (LNR) having additional contribution for predict prognosis on pathologic lymph node staging in node-positive breast cancer patients? by Kaplan, MA, Odabasi, H, Ozdemir, N, Harputluoglu, H, Aliustaoglu, M, Berk, V, Gunaydin, Y, Uncu, D, Elkiran, T, Aydin, D, Isikdogan, A

“…Abstract PURPOSE: The aim of the study was to determine whether LNR have additional contribution on pathologic lymph node staging. METHODS: To examine the…”
Get full text

Zoledronic acid and atrial fibrillation in cancer patients with bone metastases by Aksoy, S., Dizdar, Ö., Turgut, D., Sener Dede, D., Arslan, Ç., Harputluoglu, H., Altundag, K.

“…Abstract only e20591 Background: Treatment with a bisphosphonate was linked with a significantly increased risk for atrial fibrillation (AF) in a few studies…”
Get full text

Predictive factors for metastasis in patients (pts) with gastric cancer by Kilickap, S., Dizdar, O., Harputluoglu, H., Aksoy, S., Yalcin, S.

“…Abstract only 15056 Background: Determination of patients (pts) with early stage disease who have a high risk for developing metastatic disease is crucial. We…”
Get full text

Medical Plants Oils and Extracts Are an Antiproliferative Agent for Cancer Cells by Harputluoglu, H., Taştekin, D.

“…Abstract only Medical plants are consumed fresh, dried or decocted in herbal tea and they containing various products such as alkaloids have healing activity…”
Get full text